197 related articles for article (PubMed ID: 32487746)
1. Biochemical characterization of G protein coupling to calcitonin gene-related peptide and adrenomedullin receptors using a native PAGE assay.
Roehrkasse AM; Warner ML; Booe JM; Pioszak AA
J Biol Chem; 2020 Jul; 295(28):9736-9751. PubMed ID: 32487746
[TBL] [Abstract][Full Text] [Related]
2. Adrenomedullin 2/intermedin is a slow off-rate, long-acting endogenous agonist of the adrenomedullin
Babin KM; Karim JA; Gordon PH; Lennon J; Dickson A; Pioszak AA
J Biol Chem; 2023 Jun; 299(6):104785. PubMed ID: 37146967
[TBL] [Abstract][Full Text] [Related]
3. Structure-function analyses reveal a triple β-turn receptor-bound conformation of adrenomedullin 2/intermedin and enable peptide antagonist design.
Roehrkasse AM; Booe JM; Lee SM; Warner ML; Pioszak AA
J Biol Chem; 2018 Oct; 293(41):15840-15854. PubMed ID: 30139742
[TBL] [Abstract][Full Text] [Related]
4. Receptor activity-modifying protein dependent and independent activation mechanisms in the coupling of calcitonin gene-related peptide and adrenomedullin receptors to Gs.
Woolley MJ; Reynolds CA; Simms J; Walker CS; Mobarec JC; Garelja ML; Conner AC; Poyner DR; Hay DL
Biochem Pharmacol; 2017 Oct; 142():96-110. PubMed ID: 28705698
[TBL] [Abstract][Full Text] [Related]
5. Receptor activity-modifying protein-dependent effects of mutations in the calcitonin receptor-like receptor: implications for adrenomedullin and calcitonin gene-related peptide pharmacology.
Watkins HA; Walker CS; Ly KN; Bailey RJ; Barwell J; Poyner DR; Hay DL
Br J Pharmacol; 2014 Feb; 171(3):772-88. PubMed ID: 24199627
[TBL] [Abstract][Full Text] [Related]
6. Probing the Mechanism of Receptor Activity-Modifying Protein Modulation of GPCR Ligand Selectivity through Rational Design of Potent Adrenomedullin and Calcitonin Gene-Related Peptide Antagonists.
Booe JM; Warner ML; Roehrkasse AM; Hay DL; Pioszak AA
Mol Pharmacol; 2018 Apr; 93(4):355-367. PubMed ID: 29363552
[TBL] [Abstract][Full Text] [Related]
7. Selective CGRP and adrenomedullin peptide binding by tethered RAMP-calcitonin receptor-like receptor extracellular domain fusion proteins.
Moad HE; Pioszak AA
Protein Sci; 2013 Dec; 22(12):1775-85. PubMed ID: 24115156
[TBL] [Abstract][Full Text] [Related]
8. Variable CGRP family peptide signaling durations and the structural determinants thereof.
Babin KM; Gostynska SE; Karim JA; Pioszak AA
Biochem Pharmacol; 2024 Jun; 224():116235. PubMed ID: 38670438
[TBL] [Abstract][Full Text] [Related]
9. Evidence for Conservation of the Calcitonin Superfamily and Activity-regulating Mechanisms in the Basal Chordate Branchiostoma floridae: INSIGHTS INTO THE MOLECULAR AND FUNCTIONAL EVOLUTION IN CHORDATES.
Sekiguchi T; Kuwasako K; Ogasawara M; Takahashi H; Matsubara S; Osugi T; Muramatsu I; Sasayama Y; Suzuki N; Satake H
J Biol Chem; 2016 Jan; 291(5):2345-56. PubMed ID: 26644465
[TBL] [Abstract][Full Text] [Related]
10. Ectodomain structures of the CGRP and AM receptors.
Kusano S; Yokoyama S
Curr Protein Pept Sci; 2013 Aug; 14(5):375-85. PubMed ID: 23745701
[TBL] [Abstract][Full Text] [Related]
11. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
Qi T; Christopoulos G; Bailey RJ; Christopoulos A; Sexton PM; Hay DL
Mol Pharmacol; 2008 Oct; 74(4):1059-71. PubMed ID: 18593822
[TBL] [Abstract][Full Text] [Related]
12. Receptor Activity-modifying Proteins 2 and 3 Generate Adrenomedullin Receptor Subtypes with Distinct Molecular Properties.
Watkins HA; Chakravarthy M; Abhayawardana RS; Gingell JJ; Garelja M; Pardamwar M; McElhinney JM; Lathbridge A; Constantine A; Harris PW; Yuen TY; Brimble MA; Barwell J; Poyner DR; Woolley MJ; Conner AC; Pioszak AA; Reynolds CA; Hay DL
J Biol Chem; 2016 May; 291(22):11657-75. PubMed ID: 27013657
[TBL] [Abstract][Full Text] [Related]
13. Receptor Activity-modifying Protein-directed G Protein Signaling Specificity for the Calcitonin Gene-related Peptide Family of Receptors.
Weston C; Winfield I; Harris M; Hodgson R; Shah A; Dowell SJ; Mobarec JC; Woodlock DA; Reynolds CA; Poyner DR; Watkins HA; Ladds G
J Biol Chem; 2016 Oct; 291(42):21925-21944. PubMed ID: 27566546
[TBL] [Abstract][Full Text] [Related]
14. Shared and separate functions of the RAMP-based adrenomedullin receptors.
Kuwasako K; Kitamura K; Nagata S; Hikosaka T; Takei Y; Kato J
Peptides; 2011 Jul; 32(7):1540-50. PubMed ID: 21645567
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular effects of exogenous adrenomedullin and CGRP in Ramp and Calcrl deficient mice.
Pawlak JB; Wetzel-Strong SE; Dunn MK; Caron KM
Peptides; 2017 Feb; 88():1-7. PubMed ID: 27940069
[TBL] [Abstract][Full Text] [Related]
16. Structural Basis for Receptor Activity-Modifying Protein-Dependent Selective Peptide Recognition by a G Protein-Coupled Receptor.
Booe JM; Walker CS; Barwell J; Kuteyi G; Simms J; Jamaluddin MA; Warner ML; Bill RM; Harris PW; Brimble MA; Poyner DR; Hay DL; Pioszak AA
Mol Cell; 2015 Jun; 58(6):1040-52. PubMed ID: 25982113
[TBL] [Abstract][Full Text] [Related]
17. Structure-function analysis of amino acid 74 of human RAMP1 and RAMP3 and its role in peptide interactions with adrenomedullin and calcitonin gene-related peptide receptors.
Qi T; Ly K; Poyner DR; Christopoulos G; Sexton PM; Hay DL
Peptides; 2011 May; 32(5):1060-7. PubMed ID: 21402116
[TBL] [Abstract][Full Text] [Related]
18. Novel peptide antagonists of adrenomedullin and calcitonin gene-related peptide receptors: identification, pharmacological characterization, and interactions with position 74 in receptor activity-modifying protein 1/3.
Robinson SD; Aitken JF; Bailey RJ; Poyner DR; Hay DL
J Pharmacol Exp Ther; 2009 Nov; 331(2):513-21. PubMed ID: 19644039
[TBL] [Abstract][Full Text] [Related]
19. Adrenomedullin 2/intermedin in the hypothalamo-pituitary-adrenal axis.
Takahashi K; Morimoto R; Hirose T; Satoh F; Totsune K
J Mol Neurosci; 2011 Feb; 43(2):182-92. PubMed ID: 20596793
[TBL] [Abstract][Full Text] [Related]
20. Aspartate(69) of the calcitonin-like receptor is required for its functional expression together with receptor-activity-modifying proteins 1 and -2.
Ittner LM; Luessi F; Koller D; Born W; Fischer JA; Muff R
Biochem Biophys Res Commun; 2004 Jul; 319(4):1203-9. PubMed ID: 15194494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]